Skip to main content
2 May 2026
Last updated:
Tuesday 28 April 2026
User account anon menu
Login
Register and subscribe
Search
Home
News
News
Appointments
Events
About MedNous
Who We Are
Editorial Board
Editorial Policy
Research Directory
Research Directory
Organisations
Interviewees
Terms
Topics
Contact Us
Contact Form
Menu
Breadcrumb
Home
Research Directory
Research Directory
Capital efficiency -- a new norm
Read more
A new model for Pharma
Read more
A new business model for Pharma
Read more
Silence Therapeutics Plc: Consolidating the RNAi therapeutics space
Read more
For Bioalliance Pharma delivery is the innovation
Read more
Novo Nordisk Biotech Fund
Read more
How consolidation may affect biotech innovation
Read more
How Galapagos built a business from discovery
Read more
How Innate Pharma turned a threat into an opportunity
Read more
How Ablynx uses the llama to create antibodies
Read more
Pagination
First page
« First
Previous page
‹‹
…
Page
17
Page
18
Page
19
Page
20
Page
21
Page
22
Page
23
Current page
24
Page
25
Next page
››
Last page
Last »
Home
News
News
Appointments
Events
About MedNous
Who We Are
Editorial Board
Editorial Policy
Research Directory
Research Directory
Organisations
Interviewees
Terms
Topics
Contact Us
Contact Form